surmount-1 week 12 weight loss tirzepatide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are SURMOUNT‐1 study design. This is

These combined effects support applications in regenerative medicine, anti-aging research, and cellular repair studies

Results: Based on the PLS-DA models, kidney metabolites showed the highest discrimination between SC and HF (aqueous Q 2 = 0.49, organic Q 2 = 0.85), while heart metabolites showed the least (aqueous Q 2 = 0.41, organic Q 2 = -0.15)

Her $2,300 online course, GLP-1s Done Right University, includes advice on microdosing, but she advises against self-dosing and urges users to find a longevity doc who prioritises lifestyle

For Hims, the decision to offer a compounded version of Novos new Wegovy pillalbeit only brieflywas a tipping point, Novos chief counsel told STAT